IL2 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myelogenous leukemia (CML), functional NK-cell deficiency can be reversed in vitro by IL-2 (15), but this effect is progressively lost while a progressive decrease in NK-cell number is observed (16).